Two sizable IPOs are currently scheduled in the week ahead, although some smaller deals may also join the calendar throughout the week. Data center operator Csquare (CSQR) is set to raise $1.3 billion at a $3.9 billion market cap. Csquare is a...read more
Just one IPO priced this past week, joined by a handful of SPACs. Korea-listed SK hynix (SKHYV) raised $26.5 billion at a $1.1 trillion market cap in its US cross-listing. SK hynix is one of the world's largest memory semiconductor companies, ranking first...read more
Apnimed, a late-stage pharma developing oral therapies for sleep-related breathing diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Apnimed's sole clinical candidate, AD109 (Oxnimbi), is a fixed-dose,...read more
US IPO Week Ahead: Data centers and nuclear fuel names set to debut
Two sizable IPOs are currently scheduled in the week ahead, although some smaller deals may also join the calendar throughout the week. Data center operator Csquare (CSQR) is set to raise $1.3 billion at a $3.9 billion market cap. Csquare is a...read more
US IPO Weekly Recap: SK hynix raises more than $26 billion in its US IPO and trades up 13%
Just one IPO priced this past week, joined by a handful of SPACs. Korea-listed SK hynix (SKHYV) raised $26.5 billion at a $1.1 trillion market cap in its US cross-listing. SK hynix is one of the world's largest memory semiconductor companies, ranking first...read more
Obstructive Sleep Apnea pharma Apnimed files for a $100 million IPO
Apnimed, a late-stage pharma developing oral therapies for sleep-related breathing diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Apnimed's sole clinical candidate, AD109 (Oxnimbi), is a fixed-dose,...read more